Skip to main content
. 2021 Jun 8;96(23):e2801–e2811. doi: 10.1212/WNL.0000000000012060

Table 3.

I-123-metaiodobenzylguanidine (MIBG) and FP-CIT Concordance for Patients With 1 or More Lewy Body Core Symptoms

graphic file with name NEUROLOGY2020130914TT3.jpg